Literature DB >> 32643018

Investigation of the significance of population-based breast cancer screening among women aged under 40 years.

Mai Okazaki1,2, Hiroko Bando3, Eriko Tohno4, Yuka Kujiraoka5, Akiko Iguchi-Manaka6, Emika Ichioka6, Yukiko Tsushima6, Hiroshi Watanabe7, Hisato Hara6.   

Abstract

BACKGROUND: Owing to low incidence rates, population-based breast cancer screening is not recommended by many municipalities in Japan for women aged < 40 years. To evaluate the usefulness of screening in women aged < 40 years, we investigated the results of population-based breast cancer screening among young women performed in the Ibaraki Prefecture.
METHODS: Data regarding histological characteristics, recall rates, cancer detection rates, positive predictive values, tumor categories, and status of lymph node metastases were obtained from population-based screening data from Ibaraki Health Service Association Institute. The "number needing to be screened" (NNS) was determined; using Pearson's chi-squared test, these data were compared between women aged < 40 years and > 40 years.
RESULTS: The data of 428,560 women were evaluated. Cancer detection rates were significantly lower and the NNS and proportion of women with tumor category T2 or higher was significantly increased in women aged < 40 years than in those aged > 40 years (0.06% vs. 0.21%, 1505 vs. 281-439, and 28.9% vs. 6.3%, respectively; all, p < 0.05). The proportion of early-stage cancers was lower in women aged < 40 years than in those > 40 years, but this was not significant.
CONCLUSIONS: These results suggest that population-based breast cancer screening should not be recommended for women aged < 40 years. To reduce the breast cancer-related mortality rate in young women and ensure efficient use of limited medical resources in Japan, a more efficient surveillance system, based on genetic propensity and family history, needs to be established.

Entities:  

Keywords:  Breast cancer; Japan; Screening; Young women

Mesh:

Year:  2020        PMID: 32643018     DOI: 10.1007/s12282-020-01131-x

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  11 in total

1.  Harms of screening mammography for breast cancer in Japanese women.

Authors:  Yoshio Kasahara; Masaaki Kawai; Ichiro Tsuji; Eriko Tohno; Takao Yokoe; Minoru Irahara; Akira Tangoku; Noriaki Ohuchi
Journal:  Breast Cancer       Date:  2012-01-27       Impact factor: 4.239

Review 2.  Harms of Breast Cancer Screening: Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation.

Authors:  Heidi D Nelson; Miranda Pappas; Amy Cantor; Jessica Griffin; Monica Daeges; Linda Humphrey
Journal:  Ann Intern Med       Date:  2016-01-12       Impact factor: 25.391

3.  Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study.

Authors:  Florentia Fostira; Marianthi Tsitlaidou; Christos Papadimitriou; Maroulio Pertesi; Eleni Timotheadou; Alexandra V Stavropoulou; Stavros Glentis; Evangelos Bournakis; Mattheos Bobos; Dimitrios Pectasides; Pavlos Papakostas; George Pentheroudakis; Helen Gogas; Pantelis Skarlos; Epaminontas Samantas; Dimitrios Bafaloukos; Paris A Kosmidis; Angelos Koutras; Drakoulis Yannoukakos; Irene Konstantopoulou; George Fountzilas
Journal:  Breast Cancer Res Treat       Date:  2012-03-21       Impact factor: 4.872

4.  Breast cancer screening and the changing population pyramid of Japan.

Authors:  Ken Uchida; Hitoshi Ohashi; Satoki Kinoshita; Hiroko Nogi; Kumiko Kato; Yasuo Toriumi; Akinori Yamashita; Makiko Kamio; Rei Mimoto; Hiroshi Takeyama
Journal:  Breast Cancer       Date:  2013-04-30       Impact factor: 4.239

5.  The Japanese Guidelines for Breast Cancer Screening.

Authors:  Chisato Hamashima; Chisato Hamashima C; Masakazu Hattori; Satoshi Honjo; Yoshio Kasahara; Takafumi Katayama; Masahiro Nakai; Tomio Nakayama; Takako Morita; Koji Ohta; Koji Ohnuki; Motoyasu Sagawa; Hiroshi Saito; Seiju Sasaki; Tomoyuki Shimada; Tomotaka Sobue; Akihiko Suto
Journal:  Jpn J Clin Oncol       Date:  2016-02-18       Impact factor: 3.019

Review 6.  Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations.

Authors:  James D Fackenthal; Olufunmilayo I Olopade
Journal:  Nat Rev Cancer       Date:  2007-12       Impact factor: 60.716

7.  Is breast cancer the same disease in Asian and Western countries?

Authors:  Stanley P L Leong; Zhen-Zhou Shen; Tse-Jia Liu; Gaurav Agarwal; Tomoo Tajima; Nam-Sun Paik; Kerstin Sandelin; Anna Derossis; Hiram Cody; William D Foulkes
Journal:  World J Surg       Date:  2010-10       Impact factor: 3.352

8.  Tumour biomarker expression relative to age and molecular subtypes of invasive breast cancer.

Authors:  D H Morrison; D Rahardja; E King; Y Peng; V R Sarode
Journal:  Br J Cancer       Date:  2012-06-19       Impact factor: 7.640

9.  Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial.

Authors:  Noriaki Ohuchi; Akihiko Suzuki; Tomotaka Sobue; Masaaki Kawai; Seiichiro Yamamoto; Ying-Fang Zheng; Yoko Narikawa Shiono; Hiroshi Saito; Shinichi Kuriyama; Eriko Tohno; Tokiko Endo; Akira Fukao; Ichiro Tsuji; Takuhiro Yamaguchi; Yasuo Ohashi; Mamoru Fukuda; Takanori Ishida
Journal:  Lancet       Date:  2015-11-05       Impact factor: 79.321

10.  Long-term outcome in young women with breast cancer: a population-based study.

Authors:  Hanna Fredholm; Kristina Magnusson; Linda S Lindström; Hans Garmo; Sonja Eaker Fält; Henrik Lindman; Jonas Bergh; Lars Holmberg; Fredrik Pontén; Jan Frisell; Irma Fredriksson
Journal:  Breast Cancer Res Treat       Date:  2016-09-13       Impact factor: 4.872

View more
  1 in total

1.  Delineation of Pathogenomic Insights of Breast Cancer in Young Women.

Authors:  Aswathy Mary Paul; Bijesh George; Sunil Saini; Madhavan Radhakrishna Pillai; Masakazu Toi; Luis Costa; Rakesh Kumar
Journal:  Cells       Date:  2022-06-15       Impact factor: 7.666

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.